Let's talk medical research

The Foundation for Peripheral Neuropathy is a nonprofit organization whose ultimate goal is to dramatically improve the lives of those living with peripheral neuropathy (weakness, numbness, and pain caused by nerve damage). The Foundation serves as the premier resource for information for patients, families, and healthcare providers. By funding collaborative efforts of leading scientists, The ...

We caught up with Jack Burks, MD, of the Multiple Sclerosis Association of America (MSAA) to find out his thoughts on what’s new and exciting in Multiple Sclerosis research. Here’s what he had to say:

If you’ve been diagnosed with an illness, you probably know the accompanying feeling of uncertainty all too well. How will this impact your life? What treatment will you select? Will there be side effects? Will it work?

We’ve long followed the Scrip Awards - where the industry’s highest achievers are recognized for outstanding work across the drug development spectrum. And now, we’re thrilled to announce that Antidote has been named a Scrip Awards finalist in two different categories: “Best Technological Development in Clinical Trials,” for our product Antidote Match, and “Community Partnership of the Year” for ...

It’s been an exciting fall here at Antidote. We announced our latest round of funding, grew our partner network to more than 210 partners, and are now finalists for two Scrip Awards. The Scrip Awards provide the industry with the opportunity to recognize its highest achievers across the drug development spectrum— from novel deals, to new drug launches, to technological breakthroughs in clinical ...

November is COPD Awareness Month, a time that COPD patients, caregivers and organizations promote better COPD treatment and the need for research. Nearly 16 million people in the United States have been diagnosed with COPD, and it’s the third leading cause of death in the United States.

National Diabetes Awareness Month is a time to drive awareness of the disease – what it’s like to live with it, what’s the best way to treat it right now, and what research is happening that can give us a glimpse of the future of diabetes treatment and care.

Today is the first day of National Diabetes Awareness Month, and to mark the occasion, we had a conversation with three college students, Hannah, Julie, and Natali, who started their own chapter of the College Diabetes Network at the College of New Jersey.

One of the most important results of the work we do at Antidote is directly impacting the lives of patients — and getting to hear their stories is a constant reminder of why we do what we do.

We interviewed Alice Bast, CEO of Beyond Celiac, about her organization and what's next for celiac disease research.